[Drug-induced uveitis with vemurafenib: Report of two cases]

J Fr Ophtalmol. 2022 Oct;45(8):e378-e380. doi: 10.1016/j.jfo.2022.01.014. Epub 2022 May 12.

[Article in French]

Authors

Y Rivoal¹, H Bailleul², S Miocque², J-C Quintyn²

Affiliations

¹ Centre hospitalier universitaire de Caen-Normandie, avenue de la Côte de Nacre, 14000 Caen, France. Electronic address: rivoal.yannick@gmail.com.
² Centre hospitalier universitaire de Caen-Normandie, avenue de la Côte de Nacre, 14000 Caen, France.

PMID: 35570167
DOI: 10.1016/j.jfo.2022.01.014

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Antineoplastic Agents* / therapeutic use
Humans
Melanoma* / drug therapy
Skin Neoplasms* / drug therapy
Uveitis* / chemically induced
Uveitis* / diagnosis
Uveitis* / drug therapy
Vemurafenib / adverse effects

Substances

Antineoplastic Agents
Vemurafenib